secretogranin III

06/23/2023 - "Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy."
01/01/2018 - "Secretogranin III: a diabetic retinopathy-selective angiogenic factor."
01/01/2017 - "Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy."
01/01/2022 - "We recently described secretogranin III (Scg3) as a disease-selective angiogenic factor, causally linked to diabetic retinopathy and acting independently of the VEGF pathway. "
01/01/2018 - "Secretogranin III (Scg3) was recently discovered as the first highly diabetic retinopathy-associated angiogenic factor, and its neutralizing antibody alleviated the disease with high efficacy in diabetic mice. "

01/01/2022 - "Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization."
01/01/2019 - "Secretogranin III as a novel target for the therapy of choroidal neovascularization."
01/01/2022 - "Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization."

07/01/2009 - "Functional variations in the secretogranin III (SCG3) gene are associated with susceptibility to obesity. "
03/01/2007 - "Functional single-nucleotide polymorphisms in the secretogranin III (SCG3) gene that form secretory granules with appetite-related neuropeptides are associated with obesity."
02/01/2009 - "We reported that secretogranin III (SCG3) and myotubularin-related protein 9 (MTMR9) confer susceptibility to the obesity in the Japanese population. "

12/01/2017 - "Glycobiomarker, Fucosylated Short-Form Secretogranin III Levels Are Increased in Serum of Patients with Small Cell Lung Carcinoma."

09/11/2019 - "Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels."